Autotaxin-IN-5
Product Specifications
UNSPSC Description
Autotaxin-IN-5 (compound 63), extracted from patent WO2018212534A1, is an Autotaxin inhibitor. Autotaxin-IN-5 has the potential to treat idiopathic pulmonary fibrosis[1].
Target Antigen
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/autotaxin-in-5.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CCC(N=NN2)=C2C1)CN3N=C(OCC4=CC=CC=C4)C(C5=CN=C(NC6CC7=C(C=CC=C7)C6)N=C5)=C3
Molecular Weight
547.61
References & Citations
[1]LEE, Dae Yon, et al. NOVEL COMPOUNDS AS AUTOTAXIN INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME. WO2018212534A1.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-135089/Autotaxin-IN-5-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-135089/
Clinical Information
No Development Reported
CAS Number
2156655-99-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
